Where to invest $20,000 in ASX 200 shares next month

ResMed Inc. (ASX:RMD) shares are one of three that I would invest $20,000 into next month…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Rather than leaving money to gather dust in a savings account, I think now would be a great time to put it to work in the shares market.

After all, with an average return of around 9% per annum over the last three decades, the potential returns on offer are significantly greater than anything you'll find in a savings account.

With that in mind, here are three top shares that I would consider investing $20,000 into:

CSL Limited (ASX: CSL)

I think this global biotherapeutics company could be a great place to invest that $20,000. This is because I believe the company has strong long term growth prospects thanks to the quality of its products, its talented management team, and its high level of investment in research and development. I expect the latter to keep CSL at the forefront of its industry and allow it to continue generating outsized returns for investors long into the future. 

REA Group Limited (ASX: REA)

REA Group is another share that I would consider investing $20,000 into. This is due to its high quality business model and the potential rebound in the housing market in FY 2020. I believe that a rebound in housing prices could lead to the property listings company experiencing strong listing volume growth. If this were to occur, it is likely to underpin solid earnings growth next year. Especially considering how the company has managed to still grow earnings at a strong rate this year despite subdued listing volumes.

ResMed Inc. (ASX: RMD)

Another share to consider investing that $20,000 into is this medical device company which develops sleep treatment products. I'm a big fan of ResMed due to its industry-leading products and its growing market opportunity. Management estimates that there are 1 billion people impacted by sleep apnoea worldwide, but the vast majority of these people are undiagnosed. I believe the growing awareness of the condition will lead to strong market growth over the coming years and drive solid earnings growth.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended REA Group Limited and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

4 top ASX growth shares to buy and hold

Analysts think these stocks are in the buy zone right now.

Read more »

Young woman using computer laptop smiling in love showing heart symbol and shape with hands. as she switches from a big telco to Aussie Broadband which is capturing more market share
Growth Shares

Here are 4 exciting ASX growth stocks that brokers love in 2024

Brokers think investors should be snapping up these growth stocks.

Read more »

A girl is handed an oversized ice cream cone with lots of different flavours.
Growth Shares

How I'd use ASX growth shares to turn $1,000 into $10,000

Choosing the right growth shares can add plenty of bang to your buck.

Read more »

a man in a business suit points his finger amid a digitised map of the globe suspended in the air in front of him, complete with graphs, digital code and glyphs to indicate digital assets.
Investing Strategies

Future focus: How to diversify your portfolio with ASX AI ETFs

Looking for a simple and effective way to capitalise on the growth of AI technologies across global markets?

Read more »

chart showing an increasing share price
Growth Shares

Buy these excellent ASX growth shares for 15% to 20% returns

Analysts think big returns could be on the cards for owners of these shares.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Growth Shares

These ASX 200 growth shares could rise 12% to 30%

Analysts think big returns could be on offer from these shares.

Read more »

Man in an office celebrates at he crosses a finish line before his colleagues.
Growth Shares

Hoping to beat the ASX 200? I'd consider buying these 3 ASX shares

Analysts think these shares can outperform the market.

Read more »

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

5 top ASX growth shares to buy in April

Analysts think growth investors should be buying these shares.

Read more »